SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-21-109596
Filing Date
2021-04-08
Accepted
2021-04-08 08:02:27
Documents
1
Group Members
FRANKLIN ACQUISITION SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d78090dsctota.htm SC TO-T/A 38727
  Complete submission text file 0001193125-21-109596.txt   40526
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Subject) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-87623 | Film No.: 21813816
SIC: 2834 Pharmaceutical Preparations